EOSC4Cancer will make diverse types of cancer data accessible: genomics, imaging, medical, clinical, environmental and socio-economic. It will use and enhance federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR data across borders and offer them via community-driven analysis environments. Cancer’s complex nature requires integration of advanced research data across national boundaries to enable progress. The Horizon Europe mission board for cancer has identified access to data, knowledge, and digital services – accessible across the European Research Area through federated infrastructures – as a key enabling condition for success. The better we organise cancer data across Europe, the better and faster we can bring the fruits of new biological and technical innovations to the benefit of EU citizens/patients. EOSC4Cancer’s well curated data sets will be essential input for reproducible and robust analytics and computational methods – including machine learning and artificial intelligence. EOSC4Cancer’s five use cases will cover the patient journey from cancer prevention over diagnosis to treatment, laying the foundation of data trajectories and workflows for future European Cancer Mission projects. EOSC4Cancer brings together a consortium of 29 organisations from 13 countries, including cancer research centres, research infrastructures, leading research groups, hospitals, and supercomputing centres. To make the developments sustainable, EOSC4Cancer will leverage the partners’ research infrastructures partners and the EOSC ecosystem. It will also serve the European Cancer Mission, by engaging with large international coalitions (e.g., ICGC-Argo, GA4GH, 1+MG/B1MG, Cancer Core Europe, European Cancer Information System, European Network of Cancer Registries, Innovative Partnership for Action Against Cancer Joint Action) and patients/survivors associations.
Network detailsCatalogueAMC Biobank
Amsterdam UMC Biobank: Location AMC
Description
Biobanks are increasingly important for conducting state-of-the-art biomedical research. AMC Biobank has been established in 2014 to support researchers in establishing biobanks that meet current ethical and quality standards. As one of the core facilities at the Amsterdam UMC, AMC Biobank provides comprehensive storage services for biological materials as well as services related to logistics and data management. Materials can be tissues, cells, sera, plasma, liquor, urine, feces or molecular fractions, such as DNA and RNA. AMC biobank also is responsible for the central sites for ultra-low temperature freezers in the AMC at G01, Z01 and in the IWO building.
General Design
- Type
- Biobank
- Start/End data collection
- not available
- PID
- 21.12110/1.55AD-D970-9D07
- External identifiers
- bbmri-eric:ID:NL_AMCBB
Population
- Countries
- Netherlands (the)
Contributors
Subpopulations
List of subpopulations for this resource
| Name | Description | Number of participants | |
|---|---|---|---|
No results for current selection |
Networks
Part of networks